Journal of Medical Microbiology Papers in Press. Published April 10, 2014 as doi:10.1099/jmm.0.069559-0

1

A novel Omp25-binding peptide screened by phage display can 2

inhibit Brucella abortus 2308 infection in vitro and in vivo 3

Authors 4 5

Junbo Zhang 1, Fei Guo 2, Xiaoqiang Huang3, Chuangfu Chen1*, Ruitian Liu4*, Hui Zhang1, Yuanzhi Wang2, Shuanghong Yin2, Zhiqiang Li1

6

1

7

China

8

2

College of Medicine, Shihezi University, Shihezi, 832003, China

9

3

College of Life Sciences, Shihezi University, Xinjiang 832000, China

10

4

College of Life Sciences, Tsinghua University, Beijing 100083, China

*

Corresponding author:

College of Animal Science and Technology, Shihezi University, Shihezi 832003,

11 12 13 14

E-mail address: [email protected] (CC); [email protected] (RL)

15

Fax: +86-0993-2058612

16

Tel: +86-0993-2058002

17 18 19 20 21 22

23

Abstract

24

Brucellosis is a globally distributed zoonotic disease that causes animal and

25

human diseases, while current antibiotic and vaccine strategies are not optimal. The

26

surface-exposed protein OMP25 is involved in Brucella virulence and play an

27

important role in Brucella pathogenesis during infection, suggesting that Omp25 is

28

an useful target for selecting potential therapeutic molecules to inhibit Brucella

29

pathogenesis. In this study, we identified, for the first time, the specific peptides

30

bind specifically to Omp25 protein of pathogen using a phage panning technique,

31

After four rounds of panning, 42 plaques of eluted phages were subjected to

32

pyrosequencing. Four phage clones bound better than the other clones were

33

selected through the confirmation of ELISA and affinity constants. Selected

34

peptides could inhibit significantly Brucella abortus 2308 (S2308) internalization

35

and intracellular growth in RAW264.7 macrophages, and induce significantly

36

secretion of tumor necrosis factor alpha (TNF-α) and interleukin-12 in peptide- and

37

S2308-treated cells. Any observed peptide (OP11, OP27, OP35, or OP40) could

38

inhibit significantly S2308 infection in BALB/c mice. Moreover, the peptide 0P11

39

was the best candidate peptide in inhibiting S2308 infection in vitro and in vivo.

40

These results suggest that peptide OP11 has potential for exploitation as a peptide

41

drug in resisting S2308 infection.

42

Keywords: Brucella abortus 2308, Phage-display, Peptides, Inhibition infection

43 44

1. Introduction

45

Bacteria of the genus Brucella are gram-negative and facultative intracellular

46

pathogens that pose threats to animal and human health throughout the world. The

47

main pathogenic species worldwide are B.abortus and B. melitensis, which can cause

48

abortions and infertility in cattle and sheep, resulting in heavy economic losses. The

49

human disease is also caused by Brucella melitensis, Brucella abortus or Brucella

50

suis. Infection in humans can cause fever, arthritis, spondylitis, dementia, and

51

meningitis or endocarditis on rare circumstances (Elzer et al., 2002; Godfroid et al.,

52

2005; Hamdy et al., 2002).

53

Brucella spp. contain three groups of major outer membrane proteins (Omps)

54

(Dubray & Bezard, 1980; Verstreate et al., 1982). The group 3 Omps consist of two

55

related proteins of 25 (Omp25) and 31 (Omp31) kDa (Cloeckaert et al., 1996;

56

Vizcaino et al., 1996). Analysis of the omp25 gene indicates that it is highly

57

conserved in Brucella species, biovars, and strains (Cloeckaert et al., 1995). OMP25

58

are surface-exposed, a protein known to be involved in Brucella virulence, which play

59

an important role in the attachment or invasion to the host cell. Omp25 mutant of B.

60

melitensis, B. abortus, and B. ovis strains have been found to be attenuated in mice,

61

goats (B. melitensis), and cattle (B. abortus) (Edmonds et al., 2001; 2002a; 2002b).

62

Phage display technique was set up in 1985 by Smith (Smith 1985), which has

63

been proven to be a powerful tool for studying protein–protein interactions, including

64

host–pathogen interactions, bacterial adhesins, and receptor–ligand (Bair et al., 2008;

65

Pande et al., 2010). Phage random peptide library contains a pool of billions of

66

peptides that can be produced by the fusion of random nucleic acid sequences to the N

67

terminus of one of the capsid protein genes (pVIII or pIII) of a filamentous

68

bacteriophage (Cwirla et al., 1990; Devlin et al., 1990; Scott & Smith, 1990). The

69

most important feature of this technique is the direct link between the experimental

70

phenotype and its encapsulated genotype (Azzazy & Highsmith, 2002). Phage display

71

is now playing an important role in discovering peptides and antibodies that may

72

serve as novel therapeutics (Nelson et al., 2010; Fjell et al., 2011).

73

In this study, we identified, for the first time, the specific peptides bind

74

specifically to Omp25 protein of pathogenic using a phage panning technique. Our

75

results showed that the peptide 0P11 was the most effective in inhibiting S2308

76

infection compared with other three selected peptides (OP27, OP35, and OP40) in

77

vitro and in vivo, which may be useful for developing new drugs against Brucella

78

infections.

79 80

2. Materials and methods

81

Recombinant Omp25 and 32A expression and purification

82

The Omp25 open reading frames were amplified by PCR from S2308 genome.

83

The designations of the primers were based on S2308. The primer sequences

84

omp25 gene (642 bp) were as follows: sense primer, 5'-GAATTCATGCGCACTCTT-

85

AAGTCTCTCGTA-3'

86

5'-GTCGACTTAGAACTTGTAGCCGATGC 3' (SalⅠsite underlined). The amplified

87

OMP25 gene was then cloned into the pET32a vector (Novagen) to generate the

88

recombinant plasmid pET32a-Omp25. The recombinant plasmid pET32a-Omp25 was

(EcoR



site

)

underlined

and

antisense

of

primer,

89

then transformed into E. coli BL21 (DE3). Expression of recombinant protein was

90

induced with 1 mM IPTG generating N-terminally His-tagged fusion proteins. The

91

recombinant proteins (45.4 kDa) expressed from pET32a-Omp25 purified by affinity

92

chromatography with Ni2-conjugated Sepharose, and concentrated by Centricon 3

93

concentrators (Amicon). The pET32a empty vector was also transformed separately

94

into E. coli BL21 (DE3), and the protein (32A, 20.4kDa) contained the thioredoxin

95

and histidine fusion tag alone expressed and purified using the same method as above,

96

preparing for the control. The two proteins were confirmed by SDS-PAGE. Total

97

protein assays were carried out using BCA protein assay kit (Pierce, Rockford, IL,

98

USA).

99 100

Biopanning procedure

101

A cyclic 12-mer random peptide library (from New England BioLabs) was used in

102

this report. Biopanning was performed by coating a micro-plate well with 200µl of

103

purified Omp25 at a concentration of 40 µg/ml in 0.1 M NaHCO3 (pH 8.6) at 4°C

104

overnight in a humidified container. The wells were then blocked with 200 µl of

105

blocking solution (0.5% BSA + 0.1 M NaHCO3, w/v, pH 8.6) at 37°C for 1 h. The

106

phage library Ph.D. C7C were input at 2×1011 pfu/well in 100 µl of wash buffer

107

[1×TBS + 0.1% (v/v) Tween-20] and 1 h at 37°C with gentle agitation. The wells

108

were washed ten times with wash buffer to remove unbound phages. Bound phages

109

were

110

temperature and neutralized with 20 µl of 1 M Tris (pH 9.1). The eluted phage were

eluted with 200 µl of 0.2 M glycine-HCl (pH 2.2) for 10 min at room

111

titered and used to infect E. coli 2738 cells for amplification for the next round of

112

panning. Four rounds of panning were performed.

113 114

Phage tittering

115

ER2738 was inoculated and grown at 37°C to mid-log phase (OD600 ~0.5).

116

Ten-fold serial dilutions of phage containing suspension were prepared in LB-medium

117

(101 to 104 for unamplified panning eluates, 108 to 1011 for amplified cell culture

118

supernatants). Ten microliters of each phage dilution was added to 200 µl of mid-log

119

phase E. coli ER2738 and incubated with 4.0 ml of molten top agar (45° C) for 5

120

minutes. Infected cells were mixed with preheated agarose top, poured onto

121

prewarmed (37°C) LB/IPTG/X-Gal plates, and cool at room temperature for 10

122

minutes, then incubated overnight at 37°C. Phage titers were calculated by

123

multiplying the number of blue plaques by the dilution factor.

124 125

Plaque amplification

126

An overnight culture of E. coli ER 2738 was diluted 1:100 in LB and 200 µl was

127

dispensed into each microtiter well. Individual blue plaques were transferred to each

128

well and incubated at 37°C for 5 h with shaking. The microtiter plates were

129

centrifuged at 6000×g for 15 min at 4°C and the upper 80% of phage-containing

130

supernatant was collected and stored in 4°C.

131 132

Phage ssDNA extraction

133

Selected amplified phage (1 ml) from individual clones was transferred to a fresh

134

microcentrifuge tube. PEG-NaCl (400 µl) was added and incubated at room

135

temperature for 10 min. After centrifugation (15,000×g at 4°C for 15 min), the

136

supernatant was discarded, and the pellet was suspended thoroughly in 100 µl of

137

iodide buffer (10 mM Tris-HCl [pH 8.0], 1 mM EDTA, 4 M NaI). Then 250 µl of

138

ethanol was added. The mixtures were incubated for 10 min at room temperature. The

139

mixture was centrifuged at 15,000×g for 15 min and and the supernatant was

140

discarded. The pellet was washed with 70 % ethanol, dried, and suspended in 40 µl of

141

sterile double-distilled water.

142 143

Nucleotide sequencing

144

DNA content was verified by electrophoresis on agarose gels. Single-stranded

145

DNA of individual isolated phage clones was purified according to the manufacture’s

146

protocol using Qiagen miniprep kit (Valencia, CA), then sequenced with the -96gIII

147

sequencing primer (New England Biolabs) performed by the Sangon Biotech Co. Ltd.

148

(Shanghai, China).

149 150

ELISA with isolated phage clones

151

The purified fusion proteins Omp25 and 32A were applied to 96-microtiter-well

152

plates (Nunc) (10 µg/well) and incubated overnight at 4°C. Unbound proteins were

153

removed, and the wells were blocked with blocked with blocking buffer (TBST

154

contained 3% BSA) at 37°C for 1 h. Selected phage clones (1×1010/well) were added

155

and incubated for 1.5 h at 37°C. Unbound phage was removed by washing buffer

156

(PBS–0.05% Tween 20) five times for 3 min. Peroxidase-labeled anti-M13-phage

157

antibodywas added for another hour. After washing four times with washing buffer,

158

the reaction was visualized with ABTS (Sigma, Munich, Germany) and optical

159

density read at 450 nm.

160 161

Affinity constant determination

162

The affinity (Kaff) constant of peptides (OP11, OP27, OP35, and OP40) was

163

determined by the previous method using a solid-phase non-competitive enzyme

164

immunoassay (Beatty et al., 1987).

165 166

MTT assay

167

RAW264.7 macrophages were seeded at 1×104 cells/ml in 96-well plates and

168

cells were washed thrice with PBS at 0, 12, 24 and 48 hours after incubation with

169

OP11, OP27, OP35, and OP40 peptides (20 µM), and were assessed for cell viability

170

using 3-(4,5-dimethy- lthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma).

171

Fifty µl of MTT was added to each well and incubated at 37°C for 4 h. Then the

172

supernatants was removed and 100 µl of Me2SO (Sigma, USA) was added to each

173

well. Optical density was determined by eluting the dye with dimethyl sulfoxide

174

(Sigma), and the absorbance was measured at 570 nm. Three independent

175

experiments were performed.

176

177

Cell test

178

Murine macrophage RAW264.7 cells were obtained from Type Culture

179

Collection of the Chinese Academy of Sciences (Shanghai, China) and were cultured

180

in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal

181

bovine serum (FBS). The cells were routinely cultured at 37°C in a 5% CO2

182

atmosphere. To analyze the effect of peptides on S2308 internalization, RAW264.7

183

cells in 6-well plates were incubated with peptides (10 µM) and S2308 (100 MOI) at

184

37°C for 30 and 45min. Cells were washed once with medium and then incubated

185

with in DMEM with gentamicin (30µg/ml) for 30 min to kill any remaining

186

extracellular and adherent bacteria. The cells were washed three times with PBS and

187

lysed and the live bacteria were enumerated by plating on TSA plates. To determine

188

the effect of peptides on S2308 intracellular growth, the infected cells were incubated

189

at 37°C for 40 min, and the media were replaced with DMEM, peptides, and

190

gentamicin, then incubated for 4, 24, and 48 h. Cell washing, lysis, and plating

191

procedures were the same as for the analysis of S2308 internalization. At 12 and 24 h

192

postinfection, the levels of TNF-α and IL-12 in the supernatants were measured using

193

an ELISA Quantikine Mouse kit (R&D Systems). Three independent experiments

194

were performed.

195 196

Mice experiments

197

All 6-week-old female BALB/c mice were obtained from the Experimental

198

Animal Center of Academy of Military Medical Science (Beijing, PRC). The mice

199

were divided into six groups (10 mice/group). Experimental groups of mice were

200

separately injected subcutaneously with S2308 (1 × 106 CFU/mouse) and any peptide

201

OP11, OP27, OP35, and OP40 (200 µg/mouse), and the control group was injected

202

with S2308 (1 × 106 CFU/mouse) and PBS (200 μl/mouse). At weeks 2, 5, and 7,

203

experimental groups of mice were given any peptide (200 µg/mouse) and control

204

groups were given PBS (200 μl/mouse) by subcutaneously injection. At 3, 6, and 9

205

weeks, the mice were euthanised, and their spleens were removed aseptically. The

206

spleens were collected aseptically for quantitation of bacterial burden, and spleens and

207

bodies were weighed. The ratio of spleen weight to body weight was then calculated.

208

The suspensions were diluted in sterile saline and plated on TSA. The plates were

209

incubated at 37°C, and the number of CFU was counted after three days. The

210

experiments were repeated thrice with similar results.

211 212

Statistical analysis

213

The data were analyzed using Student's t-test, and were expressed as mean value

214

± standard error of the mean (S.E.M.). The P values of < 0.05 were considered

215

statistically significant.

216 217

Results

218 219 220

Recombinant Omp25 expression and purification After induction with IPTG (1.0 mM) at 37°C for 4h, E. coli BL21 (DE3)

221

harboring pET32a-Omp25 or pET32a exhibited a high level of expression (data not

222

shown). The recombinant Omp25 protein were purified using Ni-NTA affinity column.

223

The 32A protein (20.4 kDa) expressed by pET32a empty vector itself were also

224

purified as described above. The results showed that two clear target bands appeared

225

approximately at the 46 kDa and 20 kDa positions (Fig. 1).

226 227

Phage display screening

228

In order to identify peptides that specifically bind to Omp25, four rounds of

229

bio-panning were performed using a random cyclic 7-mer peptide library. A gradual

230

increase in enriched phage from 5.5 × 104 to 2 × 108 pfu was monitored after each

231

round of panning for the antigen (Table 1). Forty-two phage clones were randomly

232

picked from the fourth round output phage and were subjected to sequencing and

233

more analysis.

234 235

In vitro confirmation of binding

236

In order to confirm the binding ability of selected phage clones to Omp25,

237

forty-two independent phage clones which were randomly picked after the fourth in

238

vitro panning were tested by ELISA, and 32A protein and PBS were used as the

239

control. Phage clones OP11, OP27, OP35, and OP40 appeared to bind better than the

240

other clones (Fig. 2). When the sequences of these phage clones were analyzed by

241

DNA sequencing, it was shown that OP11, OP27, OP35, and OP40 contained the

242

peptide sequences TTSLKTF, STPSSQT, SLTTSSN, and MSPSSNT (Table 2),

243

respectively, and they have a similarity of 46.43 % analyzed using the software

244

DNAMAN with default parameters and the ClustalW algorithm for multiple sequence

245

alignment. Moreover, the affinity constants (Kaff) of the different peptides was

246

measured (Table 3), which was consistent with the results of ELISA.

247 248

Effects of peptides on the growth of RAW264.7 macrophages

249

We next investigated whether TTSLKTF, STPSSQT, SLTTSSN, and MSPSSNT

250

peptides affect the growth of RAW264.7 macrophages. The cell viability of

251

RAW264.7 macrophages incubated with peptides (20 µM) was analyzed by MTT

252

assay at 0h, 12h, 24h, and 48h. There was no loss of viability of the peptide-treated

253

macrophages compared with that of control cells (P>0.05; Fig. 3). These results

254

suggest that these peptides do not affect the survival of RAW264.7 macrophages.

255 256

Inhibition of S2308 infection by the peptides in RAW264.7 macrophages

257

The mixture of S2308 and peptides were incubated with macrophages to test

258

whether the selected peptides inhibit S2308 internalization and intracellular growth.

259

At 30 min post-infection, a significant ( P

A novel Omp25-binding peptide screened by phage display can inhibit Brucella abortus 2308 infection in vitro and in vivo.

Brucellosis is a globally distributed zoonotic disease affecting animals and humans, and current antibiotic and vaccine strategies are not optimal. Th...
230KB Sizes 0 Downloads 3 Views